We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck Discounts Significance of Vioxx Study Mistake
Merck Discounts Significance of Vioxx Study Mistake
June 2, 2006
While Merck is downplaying the significance of its misidentification of the statistical method it used to analyze data from the study that prompted the company to pull Vioxx from the market, this admission may weaken the company’s defense in the thousands of lawsuits it faces over the drug.